Lower Urinary Tract Symptoms After Intravesical Therapy
Lower Urinary Tract Symptoms After Intravesical Therapy With Mitomycin C or BCG in Patients With Carcinoma of the Bladder
Ludwig-Maximilians - University of Munich
60 participants
Apr 21, 2023
OBSERVATIONAL
Conditions
Summary
With this prospective, observational study, we would like to investigate the effect of instillation therapy using BCG or mitomycin C on short- and long-term irritative and obstructive lower urinary tract symptoms using validated questionnaires. The study will objectify the lower urinary tract symptoms and thereby provide better recommendations for therapy with mitomycin C or BCG.
Eligibility
Inclusion Criteria3
- Urinary bladder carcinoma requiring instillation therapy
- Complete resection of the tumor
- No intravesical chemotherapy in the last 3 months
Exclusion Criteria3
- Patients who are unable to complete the questionnaires
- Patients who are not willing to participate
- Patients with contraindications for instillation therapy (allergic reactions, immunosuppression)
Interventions
BPIC-SS, ICIQ-OABqol, IIEF-EF oder FSFI, ICIQ-MLUTS oder ICIQ-FLUTS
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05844059